{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:21:31Z","timestamp":1779232891543,"version":"3.51.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/spc.0b013e32836575e3","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T12:40:10Z","timestamp":1381754410000},"page":"396-405","source":"Crossref","is-referenced-by-count":7,"title":["An update on the importance of monitoring serum magnesium in advanced disease patients"],"prefix":"10.1097","volume":"7","author":[{"given":"Carlos","family":"Centeno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mario","family":"L\u00f3pez Saca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-11-20211004","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1681\/ASN.V1071616","article-title":"Hypomagnesaemia.","volume":"10","author":"Augus","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R3-11-20211004","first-page":"174","article-title":"Clinical inquiries.","volume":"54","author":"Mouw","year":"2005","journal-title":"What are the causes of hypomagnesaemia J Fam Pract"},{"key":"R4-11-20211004","first-page":"243","article-title":"Management of hypomagnesaemia in cancer patients receiving chemotherapy.","volume":"6","author":"Saif","year":"2008","journal-title":"J Support Oncol"},{"key":"R6-11-20211004","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/annonc\/mds577","article-title":"Association of hypomagnesaemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTGAGITG CO.17.","volume":"24","author":"Vickers","year":"2012","journal-title":"Ann Oncol"},{"key":"R7-11-20211004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archinte.1991.00400110049010","article-title":"Hypomagnesaemia is a frequent finding in the emergency department in patients with chest pain.","volume":"151","author":"Salem","year":"1991","journal-title":"Arch Intern Med"},{"key":"R8-11-20211004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1191\/026921600669455207","article-title":"The importance of low magnesium in palliative care: two case reports.","volume":"1","author":"Brogan","year":"2000","journal-title":"Palliat Med"},{"key":"R9-11-20211004","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/dji242","article-title":"Cetuximab therapy and symptomatic hypomagnesaemia. Brief communication.","volume":"97","author":"Schrag","year":"2005","journal-title":"Journal of National Cancer Institute"},{"key":"R10-11-20211004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2369-7-10","article-title":"Gitelman-like syndrome after cisplatin therapy: a case report and literature review.","volume":"7","author":"Kessatin","year":"2006","journal-title":"BMC Nephrology"},{"key":"R12-11-20211004","first-page":"169","article-title":"Hypomagnesaemia due to use of proton pump inhibitors a review.","volume":"67","author":"Kuipers","year":"2009","journal-title":"Neth J Med"},{"key":"R13-11-20211004","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.revmed.2009.03.012","article-title":"Les effets de lhypomagnesemie. Communications breves. The effects of hypomagnesemia. Communications brief..","volume":"30","author":"Forest","year":"2009","journal-title":"La Revue de medecine interne"},{"key":"R14-11-20211004","first-page":"1037","article-title":"Seizures secondary to hypomagnesaemia in patients with short bowel syndrome.","volume":"25","author":"Guijarro de Armas","year":"2010","journal-title":"Nutr Hosp"},{"key":"R15-11-20211004","first-page":"319","article-title":"Alucinaciones visuales y dolor inusual en relacion a hipomagnesemia en un paciente con cancer avanzado. Visual hallucinations and unusual pain in relation to hypomagnesemia in a patient with advanced cancer..","volume":"33","author":"Bosch-Barrera","year":"2010","journal-title":"An Sist Sanit Navarr"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A case series of proton pump inhibitor-induced hypomagnesaemia.","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R17-11-20211004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-155-6-201109200-00022","article-title":"Recurrent hypomagnesaemia with proton-pump inhibitor re-challenge.","volume":"155","author":"Quasdorff","year":"2011","journal-title":"Ann Intern Med"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00520-012-1669-3","article-title":"Hypomagnesemia as a possible explanation behind episodes of severe pain in cancer patients receiving palliative care.","volume":"21","author":"Lopez Saca","year":"2012","journal-title":"Support Care Cancer"},{"key":"R19-11-20211004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/NRL.0b013e31825bbf07","article-title":"Severe hypomagnesemia associated with reversible subacute ataxia and cerebellar hyperintensities on MRI.","volume":"18","author":"Boulos","year":"2012","journal-title":"Neurologist"},{"key":"R20-11-20211004","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2169\/internalmedicine.51.7748","article-title":"Hypomagnesaemia associated with a proton pump inhibitor.","volume":"51","author":"Matsuyama","year":"2012","journal-title":"Intern Med"},{"key":"R21-11-20211004","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000151346","article-title":"Magnesium ions and opiate agonist activity in streptozotocin-induced hyperalgesia.","volume":"82","author":"Bujalska","year":"2008","journal-title":"Pharmacology"},{"key":"R22-11-20211004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00210-009-0447-3","article-title":"Magnesium modifies fentanyl-induced local antinociception and hiperalgesia.","volume":"380","author":"Mert","year":"2009","journal-title":"Nauyn Schmiedebergs Arch Pharmacol"},{"key":"R23-11-20211004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000542-200002000-00029","article-title":"Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine.","volume":"92","author":"Celerier","year":"2000","journal-title":"Anaesthesiology"},{"key":"R24-11-20211004","first-page":"185","article-title":"Coadjuvant analgesics for cancer pain: using the clinical queries PubMed tool.","volume":"78","author":"Chaparro-Gomez","year":"2010","journal-title":"Cirugia y cirujanos"},{"key":"R25-11-20211004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0885-3924(99)00135-9","article-title":"The safety and efficacy of a single dose (500mg or 1g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer.","volume":"19","author":"Crosby","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"R26-11-20211004","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/bja\/89.5.711","article-title":"Efficacy of intravenous magnesium in neuropathic pain.","volume":"89","author":"Brill","year":"2002","journal-title":"Br J Anaesth"},{"key":"R27-11-20211004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1684\/mrh.2011.0282","article-title":"Oral magnesium treatment in patients with neuropathic pain: a randomized clinical trial.","volume":"24","author":"Pickering","year":"2011","journal-title":"Magnes Res"},{"key":"R28-11-20211004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arcmed.2005.01.001","article-title":"Hypomagnesaemia after major abdominal operations in cancer patients: clinical implications.","volume":"36","author":"Schwarz","year":"2005","journal-title":"Arch Med Res"},{"key":"R29-11-20211004","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000321011","article-title":"Meta-analysis of incidence and risk of hypomagnesaemia with cetuximab for advanced cancer.","volume":"56","author":"Cao","year":"2010","journal-title":"Chemotherapy"},{"key":"R30-11-20211004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/pds.3224","article-title":"Uses of proton pump inhibitors and hypomagnesaemia.","volume":"21","author":"Gau","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R31-11-20211004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1684\/mrh.2012.0325","article-title":"Hypomagnesaemia in a department of internal medicine.","volume":"25","author":"Liamis","year":"2012","journal-title":"Magnes Res"},{"key":"R32-11-20211004","first-page":"23","article-title":"Mild hypomagnesemia as the most common cisplatin nephropathy in Iran.","volume":"7","author":"Mashhadi","year":"2013","journal-title":"Iran J Kidney Dis"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T08:27:50Z","timestamp":1633508870000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e32836575e3","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}